Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies.

× No keyword cloud information.

46 in total

1. Population pharmacokinetics of mycophenolic acid and metabolites in patients with glomerulonephritis.

Authors: Wai-Johnn Sam; Melanie S Joy
Journal: Ther Drug Monit Date: 2010-10 Impact factor: 3.681

Review 2. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

Authors: Christine E Staatz; Susan E Tett
Journal: Clin Pharmacokinet Date: 2007 Impact factor: 6.447

3. Pharmacokinetics of mycophenolic acid and determination of area under the curve by abbreviated sampling strategy in Chinese liver transplant recipients.

Authors: Hao Chen; Chenghong Peng; Zhicheng Yu; Baiyong Shen; Xiaxing Deng; Weihua Qiu; Yue Fei; Chuan Shen; Guangwen Zhou; Weiping Yang; Hongwei Li
Journal: Clin Pharmacokinet Date: 2007 Impact factor: 6.447

4. Investigation on the benefits of mycophenolate mofetil and therapeutic drug monitoring in the treatment of Japanese patients with lupus nephritis.

Authors: Takayuki Katsuno; Takenori Ozaki; Takaya Ozeki; Asaka Hachiya; Hangsoo Kim; Noritoshi Kato; Takuji Ishimoto; Sawako Kato; Tomoki Kosugi; Naotake Tsuboi; Masashi Mizuno; Yasuhiko Ito; Shoichi Maruyama
Journal: Clin Exp Nephrol Date: 2018-05-23 Impact factor: 2.801

5. The emergence of mycophenolate mofetilin dermatology: from its roots in the world of organ transplantation to its versatile role in the dermatology treatment room.

Authors: Hyunhee Park
Journal: J Clin Aesthet Dermatol Date: 2011-01

Review 6. How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?

Authors: Azrin N Abd Rahman; Susan E Tett; Christine E Staatz
Journal: Clin Pharmacokinet Date: 2014-03 Impact factor: 6.447

Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies.

1. Population pharmacokinetics of mycophenolic acid and metabolites in patients with glomerulonephritis.

Review 2. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

3. Pharmacokinetics of mycophenolic acid and determination of area under the curve by abbreviated sampling strategy in Chinese liver transplant recipients.

4. Investigation on the benefits of mycophenolate mofetil and therapeutic drug monitoring in the treatment of Japanese patients with lupus nephritis.

5. The emergence of mycophenolate mofetilin dermatology: from its roots in the world of organ transplantation to its versatile role in the dermatology treatment room.

Review 6. How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?

7. Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.

8. Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors.

9. Mycophenolic acid area under the curve recovery time following rifampicin withdrawal.

10. Mycophenolic acid formulations in adult renal transplantation - update on efficacy and tolerability.